The new 19,000-square-foot, three-story facility will house the global manufacturing operations for Synovex.
Continued investment in new products and environmental impact
The company continues to invest in research and development of the product. Last year, the Food and Drug Administration (FDA) granted a label extension for Synovex Choice for use in heifers.
In 2014, the FDA completed an environmental impact review of the product, the first beef cattle implant to receive such an assessment. The FDA issued the company a FONSI (finding of no significant impact) on the environmental assessment, including waterways, air, plants or aquatic species, when used according to label directions.
“We have actively secured new label claims and new product approvals from the FDA, as well as completed the scientific research necessary to meet the FDA’s rigorous standards to protect the environment. Together with a significant investment in our manufacturing facility in Lincoln, we are taking a leap forward to meet the global demand for Synovex implants.” says Paul Parker, senior marketing manager for the company.
Quality-control testing, validation of the manufacturing facility and building inventories of the product formulations are now underway. 
—From Zoetis news release
